Skip to main content
TipRanks
Go Ultimate75% OFF

Smith & Nephew Snats (SNN) Revenue by Segment

205 Followers

Revenue by Segment

In Q2 2026, Smith & Nephew Snats reported revenue by segment of $614.00M (Orthopaedics), $527.00M (Sports Medicine & ENT) and $456.00M (Advanced Wound Management).

Analyzes revenue contributions from different business units, indicating which segments are leading growth and how diversified the company's income streams are.

$0.00$250.00M$500.00M$750.00M$1.00B$1.25B$1.50B$1.75BApr 21Jul 21Oct 21Dec 21Apr 22Jul 22Oct 22Dec 22Apr 23Jul 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Chart Insights

All three segments hit multi-year revenue highs in late‑2025, driven by new product launches and CORI-related orthopaedic momentum, signaling broad-based recovery from the pandemic trough. Orthopaedics is strengthening but remains lumpy as U.S. knee rollouts and the Integrity acquisition are phased (marginally dilutive in 2026). Advanced Wound Management has lagged and faces CMS reimbursement pressure that could offset growth despite planned cost savings. Management’s 2026 guidance implies stronger H2 revenue and profit, but tariffs, China VBP and wound pricing are key near‑term risks to monitor.

SNN Revenue by Segment

PeriodOrthopaedicsSports Medicine & ENTAdvanced Wound Management
Q2 2026Jun 30, 2026$614.00M$527.00M$456.00M
Q1 2026Mar 31, 2026$599.00M$491.00M$411.00M
Q4 2025Dec 31, 2025$667.00M$541.00M$494.00M
Q3 2025Sep 28, 2025$577.00M$469.00M$455.00M
Q2 2025Jun 29, 2025$615.00M$479.00M$459.00M
Q1 2025Mar 30, 2025$578.00M$444.00M$385.00M
Q4 2024Dec 31, 2024$608.00M$494.00M$469.00M
Q3 2024Sep 28, 2024$549.00M$441.00M$422.00M
Q2 2024Jun 29, 2024$581.00M$448.00M$412.00M
Q1 2024Mar 30, 2024$567.00M$441.00M$378.00M
Q4 2023Dec 31, 2023$576.00M$462.00M$420.00M
Q3 2023Sep 30, 2023$536.00M$425.00M$396.00M
Q2 2023Jul 01, 2023$554.00M$422.00M$403.00M
Q1 2023Apr 01, 2023$548.00M$422.00M$386.00M
Q4 2022Dec 31, 2022$549.00M$430.00M$386.00M
Q3 2022Oct 01, 2022$492.00M$382.00M$376.00M
Q2 2022Jul 02, 2022$530.00M$381.00M$382.00M
Q1 2022Apr 02, 2022$541.00M$396.00M$369.00M
Q4 2021Dec 31, 2021$552.00M$416.00M$378.00M
Q3 2021Oct 02, 2021$508.00M$379.00M$379.00M
Q2 2021Jul 03, 2021$557.00M$391.00M$387.00M
Q1 2021Apr 03, 2021$540.00M$373.00M$351.00M
Q4 2020Dec 31, 2020$545.00M$408.00M$373.00M
Q3 2020Sep 26, 2020$512.00M$350.00M$338.00M
Q2 2020Jun 27, 2020$364.00M$247.00M$290.00M
Q1 2020Mar 28, 2020$497.00M$328.00M$309.00M

Related KPIs